FOXM1 and gastric cancer: Although several E3 ubiquitin ligases targeting FOXM1 have been reported (26–31), further investigation is required to explore the prospect of FOXM1 as an anticancer target in gastric cancer, particularly with respect to its degradation via the ubiquitin-proteasome system.